This compound is a deuterated active pharmaceutical ingredient, a labeled derivative of a carbazole-based molecule where multiple hydrogen atoms have been replaced with deuterium. Its primary significance lies in its use as a research compound for pharmaceutical manufacturing and development.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1219798-86-3
Rifaximin-d6 (Major)
deuterated active pharmaceutical ingredient
Urapidil-d3 (methoxy-d3)
deuterated active pharmaceutical ingredient
(1S,3R,4S)-quinuclidin-3-yl (S)-1-(phenyl-d5)-3,4-dihydroisoquinoline-2(1H)-carboxylate
deuterated active pharmaceutical ingredient
Triamcinolone Acetonide-D6
deuterated active pharmaceutical ingredient
Donepezil-d4 (hydrochloride)
active pharmaceutical ingredient
HYDROCHLOROTHIAZIDE-3,3-D2
active pharmaceutical ingredient
Propafenone (D7 hydrochloride)
active pharmaceutical ingredient
Betaxolol-d7 (hydrochloride)
Active pharmaceutical ingredient
3-[[4,5-dideuterio-2-(trideuteriomethyl)imidazol-1-yl]methyl]-9-methyl-2,3-dihydro-1H-carbazol-4-one
FELGMEQIXOGIFQ-OIYGLIEASA-N
[2H]C1=C(N(C(=N1)C([2H])([2H])[2H])CC2CCC3=C(C2=O)C4=CC=CC=C4N3C)[2H]
—